TCU offensive lineman Marcus Cannon has tested positive for a treatable form of lymphoma after a battery of tests, a league source tells PFT.
The good news for Cannon is that this form of non-Hodgkin lymphoma is treatable. The timing of the news is unfortunate of course just days before the draft.
A rumor was circulated last month that Cannon had testicular cancer, which isn’t true. A biopsy was then performed to clear the matter up, with the results sent to all 32 teams.
Unfortunately, the results of the biopsy showed that Cannon has lymphoma. Doctors had previously been aware of a benign mass that was present for years and is in his stomach/pelvic area.
Doctors are recommending that Cannon will have to undergo chemotherapy, which could be potentially finished in 12 weeks. Even if Cannon has the most advanced stage of the disease, he could be finished with treatments in 24 weeks and the doctors have informed Cannon he could “hopefully” continue with his football career at that time.
We wish Cannon all the best at this difficult time as he readies to treat the disease.